Double maintains 1 strategies that include NRIX - Nurix Therapeutics, Inc.
Current Value
$12.461 Year Return
Current Value
$12.461 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BSV | 0.09% | $38.39B | 0.03% |
SPTI | 0.19% | $8.82B | 0.03% |
STIP | -0.19% | $12.72B | 0.03% |
SCHR | 0.19% | $10.92B | 0.03% |
CGMU | 0.21% | $3.36B | 0.27% |
SHY | -0.23% | $23.83B | 0.15% |
IBTL | 0.23% | $381.01M | 0.07% |
CMF | 0.24% | $3.59B | 0.08% |
STXT | 0.43% | $129.40M | 0.49% |
IBTM | 0.45% | $316.49M | 0.07% |
TAXF | 0.51% | $489.34M | 0.29% |
HYMB | -0.65% | $2.63B | 0.35% |
ICSH | 0.71% | $6.02B | 0.08% |
UTEN | 0.88% | $210.24M | 0.15% |
CORN | -0.89% | $44.67M | 0.2% |
IBMN | -0.93% | $447.08M | 0.18% |
GOVT | 0.95% | $27.54B | 0.05% |
IBTK | -0.95% | $448.89M | 0.07% |
GSST | -0.96% | $921.46M | 0.16% |
IBTO | 0.96% | $352.69M | 0.07% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -16.97% | $24.23B | +35.36% | 1.09% |
CME | -12.32% | $99.39B | +40.68% | 3.86% |
T | -9.07% | $203.71B | +51.55% | 3.92% |
ED | -7.22% | $36.00B | +12.64% | 3.34% |
VSTA | -7.00% | $344.07M | +39.29% | 0.00% |
VZ | -6.18% | $183.79B | +6.01% | 6.18% |
ZCMD | -6.07% | $29.55M | -8.59% | 0.00% |
VSA | -5.30% | $8.67M | -19.04% | 0.00% |
KMB | -5.11% | $43.92B | -3.75% | 3.75% |
NOC | -5.10% | $71.81B | +14.14% | 1.69% |
AMT | -4.91% | $104.32B | +14.40% | 3.00% |
VHC | -4.66% | $48.19M | +108.24% | 0.00% |
CNC | -4.54% | $16.81B | -49.40% | 0.00% |
TEF | -4.33% | $30.08B | +25.41% | 6.16% |
NEUE | -3.76% | $61.24M | +29.92% | 0.00% |
AWK | -3.56% | $27.36B | +9.65% | 2.21% |
AIFU | -3.49% | $6.79B | +102.19% | 0.00% |
CYCN | -3.36% | $10.59M | +46.35% | 0.00% |
MKTX | -3.36% | $8.22B | +9.03% | 1.38% |
MO | -3.13% | $99.67B | +28.77% | 6.90% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -40.44% | $164.54M | 0.85% |
BTAL | -40.08% | $296.22M | 1.43% |
TAIL | -37.26% | $99.63M | 0.59% |
IVOL | -17.84% | $347.03M | 1.02% |
TBLL | -10.79% | $2.13B | 0.08% |
XONE | -10.52% | $625.28M | 0.03% |
TPMN | -10.48% | $30.70M | 0.65% |
ULST | -10.46% | $654.75M | 0.2% |
FXY | -10.29% | $816.38M | 0.4% |
JMST | -9.94% | $4.06B | 0.18% |
SPTS | -9.65% | $5.80B | 0.03% |
XHLF | -9.13% | $1.73B | 0.03% |
UTWO | -8.47% | $379.52M | 0.15% |
DFNM | -8.35% | $1.57B | 0.17% |
TFLO | -7.78% | $6.82B | 0.15% |
SCHO | -7.54% | $11.03B | 0.03% |
CANE | -6.97% | $10.37M | 0.29% |
FTSD | -6.65% | $231.81M | 0.25% |
CLIP | -6.41% | $1.51B | 0.07% |
VGSH | -5.92% | $22.80B | 0.03% |
Yahoo
Nurix Therapeutics (NRIX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Yahoo
The mean of analysts' price targets for Nurix Therapeutics (NRIX) points to a 143.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Yahoo
Immunome (IMNM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Finnhub
Nurix Therapeutics, Inc. dropped from Russell Microcap Growth Index...
Finnhub
Nurix Therapeutics, Inc. dropped from Russell 3000E Growth Index...
Yahoo
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KYMR | 65.35% | $3.12B | +47.65% | 0.00% |
DNLI | 61.06% | $2.16B | -30.05% | 0.00% |
IDYA | 57.51% | $1.92B | -34.15% | 0.00% |
BEAM | 55.97% | $2.00B | -15.33% | 0.00% |
RNA | 55.07% | $3.54B | -21.10% | 0.00% |
OCUL | 53.33% | $1.51B | +41.41% | 0.00% |
CRNX | 52.73% | $2.76B | -33.39% | 0.00% |
XENE | 51.90% | $2.56B | -7.61% | 0.00% |
STOK | 51.01% | $630.59M | -8.84% | 0.00% |
SYRE | 50.98% | $935.48M | -39.83% | 0.00% |
IMNM | 50.78% | $750.92M | -28.80% | 0.00% |
ATXS | 50.27% | $323.37M | -36.33% | 0.00% |
RVMD | 50.09% | $6.93B | +0.73% | 0.00% |
ZYME | 49.91% | $905.57M | +53.64% | 0.00% |
RARE | 49.83% | $3.73B | -1.87% | 0.00% |
APGE | 49.61% | $2.64B | +18.19% | 0.00% |
SNDX | 49.24% | $774.43M | -55.18% | 0.00% |
CGON | 49.23% | $2.03B | -13.46% | 0.00% |
DYN | 49.06% | $1.02B | -73.78% | 0.00% |
CLDX | 48.03% | $1.47B | -38.43% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 66.55% | $4.82B | 0.35% |
GNOM | 61.86% | $44.57M | 0.5% |
IBB | 60.59% | $5.26B | 0.45% |
ARKG | 58.54% | $1.02B | 0.75% |
PTH | 57.88% | $100.85M | 0.6% |
PBE | 57.64% | $223.19M | 0.58% |
XPH | 57.59% | $147.96M | 0.35% |
IWC | 54.09% | $818.14M | 0.6% |
FBT | 53.20% | $1.01B | 0.54% |
IWO | 53.14% | $11.60B | 0.24% |
PINK | 52.77% | $130.57M | 0.5% |
VTWO | 51.45% | $12.52B | 0.07% |
IWM | 51.44% | $63.72B | 0.19% |
BBH | 51.06% | $330.62M | 0.35% |
RDTE | 50.78% | $137.93M | 0.97% |
KJUL | 50.00% | $119.50M | 0.79% |
SCHA | 49.97% | $17.26B | 0.04% |
ISCG | 49.89% | $681.20M | 0.06% |
KJAN | 49.66% | $287.30M | 0.79% |
IWMY | 49.21% | $119.32M | 1.02% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GORV | -0.13% | $27.07M | -91.17% | 0.00% |
KR | 0.14% | $46.43B | +38.38% | 1.85% |
CREG | -0.19% | $5.77M | -79.16% | 0.00% |
LTM | -0.21% | $12.63B | -95.46% | 2.42% |
GFI | 0.23% | $21.56B | +57.55% | 2.31% |
CPSH | -0.59% | $42.27M | +74.25% | 0.00% |
MCK | -0.59% | $88.11B | +20.93% | 0.40% |
MNOV | -0.60% | $62.29M | -9.29% | 0.00% |
STG | -0.61% | $30.78M | -22.51% | 0.00% |
CCRN | 0.72% | $429.13M | -3.89% | 0.00% |
MDLZ | 0.86% | $90.07B | +4.85% | 2.72% |
K | 0.88% | $27.76B | +41.17% | 2.85% |
EXC | -0.88% | $43.33B | +23.58% | 3.62% |
AQB | 0.98% | $2.96M | -53.35% | 0.00% |
LRN | 0.99% | $5.99B | +100.06% | 0.00% |
BTCT | 1.00% | $25.56M | +61.14% | 0.00% |
DFDV | 1.11% | $300.56M | +2,130.16% | 0.00% |
DAO | 1.28% | $262.76M | +119.32% | 0.00% |
AEP | -1.29% | $55.16B | +17.93% | 3.54% |
HUSA | 1.37% | $19.66M | -19.53% | 0.00% |